Most Serious Side Effects of Lacosamide
Lacosamide (Vimpat), used to treat partial-onset seizures, carries risks of severe effects including cardiac arrhythmias, multi-organ hypersensitivity reactions, and suicidal thoughts. The FDA black box warning highlights these, with cardiac risks stemming from PR interval prolongation that can lead to atrioventricular block.[1][2]
Cardiac Risks Patients Report
Heart rhythm disturbances top concerns, including AV block (first-, second-, or third-degree), bradycardia, atrial fibrillation, and ventricular tachycardia. These risks increase with higher doses, existing conduction issues, or concurrent sodium channel blockers. Symptoms include fainting, dizziness, or palpitations; ECG monitoring is recommended before and during treatment.[1][3]
Allergic Reactions and DRESS Syndrome
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) or Stevens-Johnson syndrome can occur, involving rash, fever, swollen glands, liver/kidney damage, and eosinophilia. Discontinue immediately if rash appears; onset is typically 2-8 weeks after starting.[1][2]
Suicidal Behavior Warning
Antiepileptic drugs like lacosamide double suicide risk. Monitor for mood changes, depression, or agitation, especially early in treatment. Patients with seizure disorders already face higher baseline risk.[1][4]
What Happens with Overdose?
Overdose causes severe CNS depression, cardiac arrest, coma, or respiratory failure. No specific antidote exists; treatment is supportive with activated charcoal, intubation, and lipid emulsion for cardiac toxicity.[1][5]
Risks in Special Populations
Elderly patients face amplified cardiac and renal risks due to slower clearance. Avoid in those with severe hepatic impairment or second/third-degree AV block. Pregnancy category C; use only if benefits outweigh fetal neural tube defect risks.[1][3]
How Common Are These?
Serious cardiac events occur in <1% of patients, DRESS in rare cases (<0.1%), and suicidality signals are class-wide (0.43% vs. 0.24% placebo). Report via FDA MedWatch.[1][2][4]
[1]: FDA Vimpat Label
[2]: Drugs.com - Lacosamide Side Effects
[3]: Epilepsy Foundation - Lacosamide
[4]: FDA AED Suicidality Warning
[5]: RxList - Vimpat Overdose